- Home
- FENG vs AEON Comparison
FENG vs AEON Comparison
Compare FENG & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENG | AEON |
|---|---|---|
| Founded | 1998 | N/A |
| Country | China | United States |
| Employees | N/A | 8 |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 19.0M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | FENG | AEON |
|---|---|---|
| Price | $1.53 | $0.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 2.0K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.39 | $0.22 |
| 52 Week High | $3.65 | $1.45 |
Technical Indicators
Market Signals| Indicator | FENG | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 29.36 |
| Support Level | $1.50 | $0.26 |
| Resistance Level | $1.80 | $0.34 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 87.50 | 46.52 |
Price Performance
Historical ComparisonAbout FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives all of its revenue from PRC.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.